Your browser is old and is not supported. Upgrade for better security.

Venomyx Therapeutics

EpiPen for snakebites: the antivenom of tomorrow!

Last Funded July 2019

$290,122

raised from 505 investors

Highlights

1
10x more effective than conventional antivenom.
2
Our antivenom saved 100% of mice from whole snake venom.
3
Our antivenom is made in bacteria instead of horses = cheaper and faster to produce.
4
Since it's made in bacteria, there are fewer risks of negative side effects in humans.
5
Vipax is stable at room temperatures for portability.
6
International patent for antivenom composition and methods.
7
$250K committed to $1.2M round so far.

Our Team


Downloads

Overview